chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On my bedside evaluation this is a 64-year-old man who presents to the emergency department with weakness in the right face, right upper extremity, right lower extremity.  Patient states that all of his symptoms started around 10 PM, he is feeling like he cannot swallow correctly because he is drooling, has trouble with his right arm and right leg, has been having difficulty walking.  He was seen at the end of December for TIA, at that time his imaging was normal, MRI was not able to be done because of the metal fragment in his eye.  He has not really followed up outpatient.  He was found at that time to have carotid stenosis.     On evaluation the patient has a stroke scale of 4 with a right-sided facial droop, right arm with drift, right leg with drift and ataxia.  Otherwise he has normal heart sounds, clear lung sounds, a soft abdomen which is nontender.  The patient is alert and oriented x4.  Patient states that he was only supposed to take the Plavix for 1 month so he has finished this medication at the end of January and did not continue it, per his notes however he was meant to take it for 1 year.  He also has not had his Holter monitor study scheduled followed up with neurology outpatient.  We did elect to send the patient for P1 stroke scans, we did speak with neurology who feel that the patient is outside of the TPA window but feel that he would benefit from hospitalization
Several neurological impacts, including slurred speech, leg pain, tremors, slowed comprehension, and as days went by leading up to hospitalization, loss of ability to speak in complete sentences.
pt rec;d grey cap pfizer vaccine after being in the freezer for 22 days- pt not interested in replacement dose
Neck stiffness; Severe bone and joint pain throughout legs, hands, feet, knees, neck.; Severe bone and joint pain throughout legs, hands, feet, knees, neck.; Pins and needle sensations in left hand; Weakness in hands; Terrible Headache; Nausea; Fatigue; Sleepiness; Difficulty thinking clearly; Tenderness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 29Apr2021 at 14:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included Lyme disease and lactose allergy. Concomitant medications included multi-vitamins, ibuprofen (MANUFACTURER UNKNOWN) and allergy medication for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 07Apr2021 at 14:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01May2021 at 06:00, the patient experienced neck stiffness, severe bone and joint pain throughout legs, hands, feet, knees, neck, pins and needle sensations in left hand, weakness in hands, terrible headache, nausea, fatigue, sleepiness, difficulty thinking clearly and tenderness at injection site. Patient didn't receive treatment for events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, or emergency room/department or urgent care. The clinical outcome of the events was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient had an episode of fainting for about 30 seconds after receiving intradermal jynneos vaccination for Monkeypox. After pt recovered from fainting, he was alert and oriented x3. He complained of feeling cold, clammy and diaphoretic. Pt was later flat, vitals initiated and offered water. Pt observation was extended for 30 minutes. Pt stated he felt much better after observation ended. Pt was able to walk with a steady gait, denied any of the earlier symptoms mentioned. Left in stable condition via ambulatory. Encouraged to seek medical attention for any adverse reactions.
Pt receieved her first dose of the Moderna COVID-19 on 12/29/2020.  Lot number, route, and site not specified in medical record.  No record of 2nd dose was found on medical record review.  Pt was admitted to reporting hospital 2/2/2021 with an admitting diagnosis of failure to thrive/poor oral intake.  Pt was reported in ER to have a sore throat, cough, shortness of breath, and general recent decline.  Reported that pt and others in family had GI like illness about a week ago.  Admission test for COVID was positive per PCR NP swab on 2/2/2021.  Pt still currently admitted.
rash from head to toe; patient reported to Pharmacy manager.  follow up visit with PCP.  PCP prescribed 4 mg medrol dose pack
Adverse event: 2 of 7 people received a more concentrated dose of the vaccine. One vial of two was diluted incorrectly with less Normal Saline than require. This error was not noticed until person mixing vaccine said they were out of vaccine and did not have enough to get 5 dosages of 0.3ml. Two people mixed one vial of vaccine together demonstrating to the other. It appears the person making the error did not notice they did not have 1.8ml of NS but must have had some air and did not realize it. The error was noticed when all the vaccines were given and one person had not completed pulling up the vaccine. So, 2 of 7 patients received the incorrect dose of vaccine and it could not be determined which two received the incorrect dose. Patient reported next day of having swollen lymph nodes, soreness, chills, slight headache--
Information has been receive from a registered nurse concerning a 26 month old white female with no known allergies or history who on 16-FEB-2005 was vaccinated in the left arm with a first dose of varicella virus vaccine live (lot# 648757/0594P). There was no illness at the time of vaccination. On 02-FEB-2006 the patient developed 5 lesions on trunk with patches of eczema. Unspecified medical attention was sought. The patient was treated with diphenhydramine hydrochloride (BENADRYL) and topical skin care. No laboratory diagnostic tests were performed. Subsequently, the patient recovered.  No further information is available.
I cant use my right hand, weak wrist ,fingers doesnt work, feel numbnesssometimes mostly in a hand, fewtimes felt higher in an arm, sometimesfeel numbness in my face, aroundeyes; felt right arm was coldcomparing with left, primary caredoctors impression - paresthesia afterreceiving vaccine.; I cant use my right hand, weak wrist ,fingers doesnt work,; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7533 (not sure)) via an unspecified route of administration in the right arm on 02Apr2021 at 09:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Patient had no allergies to food, medications or other products. Patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 03Apr2021, the patient stated that she could not use her right hand, weak wrist, fingers did not work, felt numbness sometimes mostly in a hand, few times felt higher in an arm, sometimes felt numbness in face, around eyes. Felt right arm was cold comparing with left, primary care doctor's impression paraesthesia after receiving vaccine. Patient was referred to neurologist. Patient will be seeing neurologist at the end of the month. Patient next vaccine shot was scheduled at May 1st and was very concern to take vaccine. The patient did not receive any treatment for the events. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events numbness, could not use her right hand, weak wrist, fingers did not work, felt numbness sometimes mostly in a hand, few times felt higher in an arm, sometimes felt numbness in face, around eyes and paraesthesia were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
heart palpitations after getting the vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from Medical Information Team for a Pfizer-sponsored program (159558).  A 35 year-old female patient received BNT162B2 (COMIRNATY, solution for injection), administration date 2021 (Batch/Lot number: unknown) as dose 1, single and administration date 2021 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation; escitalopram oxalate (LEXAPRO), oral (Batch/Lot number: unknown) till 2021 at 10 mg 1x/day for anxiety. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: PALPITATIONS (non-serious) with onset 2021, outcome "recovering", described as "heart palpitations after getting the vaccine". The event "heart palpitations after getting the vaccine" was evaluated at the physician office visit. The action taken for escitalopram oxalate was dosage permanently withdrawn on 2021. Additional information: The patient recently started seeing the doctor that she worked for and reported feeling heart palpitations after getting Pfizer COVID vaccine. The patient had been taking Lexapro for about 7 years and has been off Lexapro since about two months ago, after getting the second dose of the vaccine. The reporter said it would have been during the last 5 months after vaccine, and the patient said with Lexapro the vaccine increased heart palpitations. The patient did say her heart palpitations were better after being off Lexapro. The reporter clarified that the patient is on Lexapro, and not Zoloft, and she didn't experience palpitations before taking the vaccine, so they wanted to know if they had reports of this before. The reporter was looking to see if reactions were reported with Zoloft since Pfizer manufactures Zoloft, which was another SSRI, and if reactions were reported with SSRIs.  The lot number for BNT162B2, was not provided and will be requested during follow up.
05/19/2022, I had a knee replacement 16 years ago. My knee began to swell, it felt hot. My big toe on my right foot was swollen, a little red and hot. On that same foot, the right ankle was swollen and hot. I had to get my old walker out to walk around because I was so unsteady. 05/20/2022, I went to my orthopedist. He took x-rays, did a physical exam and looked at my right foot as well. He said the prosthesis was not loose. He did not feel it was infected. He thought, perhaps, I had gout. He said I had a little bit of an infection. He prescribed an anti-inflammatory and told me to return in 2 weeks. It is now much better.
Chilblains on left fingers; This is a spontaneous report from a non-contactable consumer or other non hcp. A 33-years-old non-pregnant adult female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection),via an unspecified route of administration, administered in Left arm on 26May2021 at 09:00 (at the age of 33y-ears old) as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient medical history was reported as none. Allergies were reported as None. The patient concomitant medications were not reported. No COVID occurred prior vaccination. No COVID test was taken post vaccination No other vaccine was taken in four weeks of vaccination. No other medications were taken in two weeks of vaccination. On 27May2021at 19:00, the patient experienced chilblains on left fingers. The outcome for the events Recovering/Resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recv vax 30JUL97 & AUG97 pt devel a few lesions of chickenpox on rt back;pt was otherwise asymptomatic;15AUG97 pt recovered; Follow-up information received from a healthcare professional concerning a 27-year-old Caucasian patient with "gastroesophageal reflux disease, hiradenitis right axilla" and bulimia who on July 30, 1997 was vaccinated with one dose of varicella vaccine (lot #621195/0638E) SC in left arm. In August of 1997, the patient developed a few lesions of chickenpox on her right back. She was otherwise asymptomatic. On August 15, 1997, the patient recovered.
This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received DTPa-IPV (Kinrix) (batch number E2L54, expiry date 3rd March 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 20th December 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 20th December 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The practice manager reported that, it was recently discovered that Kinrix vaccine was administered to the infant patient instead of Pediarix, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up. This is one of two cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022001230:same reporter.
pt was given Heplisav-b instead of menveo which was the intended vaccine. patient has had hep b  vaccinations in the past as stated from Provider this is no harm to patient. Provider called patient and patient had no symptoms and was fine.  no treatment was necessary, only that he had to come in a few days later to get the correct vaccine. in which he was evaluated at that time as well.
rash on arms - one red spot on the left arm and bruising on the right forearm and right knee
RN gave IM injection too high on the arm resulting in severe pain and immobility x 5 days. Patient felt pain very soon after injection and circled the needle mark of the injection site. Patient reported to public health department on day 6 after injection to ask if this was an expected reaction after a vaccine or if it was because the injection was too  high. The location that the patient marked was indeed over the shoulder and not in the deltoid muscle. The RN who gave the injection has not done patient care in 20+years. The injection was co-signed by public health department staff.  Patient reports that on day 6 the pain had decreased a small amount and that strength is returning to his hand.
PATIENT RECEIVED VACCINE,  WENT TO HER CAR TO WAIT, WITHI N 10 MINUTES RETURNED TO PHARMACY STATING SHE HAD FAINTED AND FELT LIKE SHE WAS GOING TO FAINT AGAIN.  PATIENT WAS RETURNED TO SITTING WITH FEET ELEVATED, TOOK BLOOD PRESSURE, WHICH WAS 80/50. SHE WAS C LAMY AND STILL FEELING FAINT. ALSO STATED SHE HAD NOT EATEN. EMS WAS CALLED AND THEY EVALUATED THE PATIENT AND DETERMINED HER BLOOD GLUCOSE WAS LOW. SHE GOT A SNACK AND LEFT WITH A FAMILY MEMBER. NO FURTHER MEDICAL ATTENTION WAS GIVEN.
Moderna COVID-19 Vaccine EUA  Patient received vaccine at 1140 and began to feel symptomatic at 1150. Experienced coughing, was clearing throat, increased work of breathing and stated it felt heavy to breathe. Vitals obtained at 1204 were BP 156/96, HR 80, RR 14, o2 100%. Breath sounds congested upper and lower left lobes. Right lung clear.
The patient stated that she felt "woozy", had shakes, and nausea/vomiting x1. The patient's vitals  167/108 L arm 92HR   at 0759 and 154/99 R arm 87HR at 0802. The patient was given 25mg of Diphenhydramine oral solution  at 0805. The patient was also reclined. The blood pressure was rechecked 188/116 L arm 88HR at 0833 and 172/92 R arm at 0835. The patient's supervisor was then notified to come. The patient gave permission for information to be shared with supervisor. The patient voiced understanding that she should go seek medical attention and treatment from hospital or her own personal doctor. The patient also voiced understanding that she cannot drive herself due to Diphenhydramine intake.  The patient's supervisor is witness to patient voicing understanding on both occasions.
My husband has hereditary hearing loss and tinnitus, the ringing in the ears, and with each new vaccine the tinnitus gets a little bit louder; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 68-year-old male patient received BNT162b2 (BNT162B2), on 10Mar2021 as dose 1, single (Lot number: EN6206) at the age of 68 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "hearing loss" (ongoing), notes: has for about 20 years; "tinnitus/ringing in the ears" (ongoing); "hearing aide" (ongoing), notes: wears hearing aides and has for about 20 years. There were no concomitant medications. The following information was reported: TINNITUS (non-serious) with onset 2021, outcome "not recovered", described as "My husband has hereditary hearing loss and tinnitus, the ringing in the ears, and with each new vaccine the tinnitus gets a little bit louder". Therapeutic measures were not taken as a result of tinnitus. Additional information: The reporter is calling about her husband and the Pfizer vaccine. Before they had the original two vaccines and two boosters. Her husband has hereditary hearing loss and tinnitus, the ringing in the ears, and with each new vaccine the tinnitus gets a little bit louder, and it does not come back down, it stays in an elevated level, it has happened every time. The reporter asked, "How should we approach this, do we continue taking the vaccine, and make the tinnitus even louder?". She wants to know what is in the vaccine that is causing her husband to have tinnitus, which becomes louder every time he receives the shot. They decided to choose Pfizer over other COVID-19 vaccines despite the reports about the safety. No treatment for tinnitus that know of. No prior vaccinations (within 4 weeks).
Narrative:  Patient stated to the RN that she was immunocompromised, and a 0.25 mL dose of the booster was administered to the patient. RN was educated on the appropriate dose and patient is being contacted by the Health Authority to administer a 0.5 mL dose.
incorrect dosage administered to client. client received 2 doses of 0.2 ml instead of 0.25 ml. one dose on 4/25/23 and one dose 5/25/23 at 6 months of age and 7 months of age.
I started feeling cold my teeth started chattering. I couldn't get warm even while under a heated blanket. Prior to this immediately after I got the shot I had a fever and was extremely thirsty. I emailed my doctor and they advised me to come in to make sure there was nothing going on. My temperature had dropped to 94 or 95 degrees and I was advised I had mild hypothermia. I went in to the doctor and my temperature had adjusted. I was advised my symptoms were normal as a result of the vaccine. If things were not better within 3 weeks I would need to go back for bloodwork.
Patient had vasovagal response to injection. Has history of vasovagal response to needles. Pt became lightheaded, diaphoretic, pale. Was incontinent of bladder. Denied hx of seizures. Patient stated he woke up late and didn't eat breakfast or drink fluids. Assessed by onsite paramedics  -HR 83, SPO2 100% on room air, BP 132/84. Pt was observed for 30 minutes and provided with water. Refused transport to hospital for further assessment. Advised patient to seek emergency help if symptoms return. Pt verbalized understanding.
Initial report received from a healthcare professional on 21 January 2014. A male patient whose medical history and concomitant medications were not reported, had received a dose of FLUZONE HD (batch number, dose number, route and site of administration not reported) on an unspecified date. On an unspecified date, 3 days after vaccination, the patient developed severe pain in the left arm. Laboratory tests and corrective treatments were not reported. The patient visited the ER. At the time of this report, the outcome was unknown. List of documents held by sender: None. Follow-up information received from healthcare professional on 24 March 2014. It was reported that, on an unspecified date, the outcome was recovered.
He received both doses March 2021. second dose on 3/26. on 4/26 presented to ER with Epistaxis, came to about a month after Pfizer series pt went to Hospital ER 3 times that week for care of what was thought nose bleeds from picking, and later ENT for care that required travel. Pt stopped Plavix use and 6 days later on 5/1 returned to Hospital ER with serious symptoms, developed multiple thrombotic events that lead to clotting of leg/bowel/coronary. Transferred to Hospital on 5/1/2021. Multiple MI events and expired at Hospital on 5/3/2021
Headache, Fever, Fatigue, joint pain, increased temperature, swollen lymph nodes Narrative:
Client was given 2nd dose 10 days early.  The donor was given her first dose on 09/03/2021, her vaccination card was misread as 09/30/2021 by admin staff and vaccinator.  It was not noticed when they were in system either.  The client had no complaints and no sign of any problems.  The APRN was contacted by Team Lead, she instructed me to inform client that at this time, there is no need to restart the series, or get another dose.  Client was informed.
I was on my 5th day of my menstrual cycle, which is nearly the end of my cycle, but the next day (day 6 of my menstrual cycle) I have severe menstrual cramps and fresh and heavy bleeding, as if it was day 1 of my menstrual cycle.  I have had off and on severe bleeding and menstrual cramps since that day.
This spontaneous report was received from a health professional refers to a 65 year old female patient. Patient's pertinent medical history included seizures. Drug reactions/allergies were unspecified. On 26-MAR-2015 the patient was administered with ZOSTAVAX, .65 ml (lot # L002422, expiry date: 23-APR-2016) for routine vaccination. Concomitant therapies included DILANTIN. The patient experienced dizziness on 26-MAR-2015 following the administered of ZOSTAVAX. The patient sought medical attention and went to the pharmacy. Lab diagnostic studies were unspecified. Treatment given for the event was unspecified. Outcome of the event was not recovered. Causality assessment was not provided. Additional information has been requested.
Menstrual period now lasts approximately 20-30 days. I have bleeding more days of the month than not.
I had vommiting for about 10 minutes when I got up and showered.  I was cold, sore and tired for most of the day.
After vaccines were administered to patient at 11:50 AM, patient was advised to wait 30 minutes for monitoring. Patient was speaking to the nurse for about 5 minutes and the patient started hyperventilating and complaining of numbness to both arms and cramping on both hands. Patient remained alert and oriented x3. Nurse remained with patient and measures were done to attempt to calm patient down. Patient calmed down and was breathing normally, and minutes later started hyperventilating again and rashes were observed on patient's upper chest. Telephone call made to 911 for emergency intervention.